Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Pföhler, C; Ugurel, S; Seiter, S; Wagner, A; Tilgen, W; Reinhold, U.
Interferon-alpha-associated development of bullous lesions in mycosis fungoides.
Dermatology. 2000; 200(1):51-53 Doi: 10.1159/000018317 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Co-Autor*innen der Med Uni Graz
Ugurel-Becker Selma
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
We report a 67-year-old woman with mycosis fungoides (MF) who was receiving subcutaneous injections of recombinant interferon alpha-2b (IFN-alpha). After 2 months of IFN-alpha treatment, bullous lesions appeared on her trunk and extremities. A skin biopsy specimen from the trunk revealed histopathologic features of bullous MF. Bullous lesions with specific infiltrates of MF are very rare; to the best of our knowledge, this is the first case showing specific bullous lesions of MF developed under IFN-alpha treatment.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Antineoplastic Agents - adverse effects Antineoplastic Agents - therapeutic use
Female -
Humans -
Interferon Type I, Recombinant - adverse effects Interferon Type I, Recombinant - therapeutic use
Mycosis Fungoides - drug therapy
Skin Diseases, Vesiculobullous - chemically induced
Skin Neoplasms - drug therapy

Find related publications in this database (Keywords)
cutaneous T cell lymphoma
bullous mycosis fungoides
interferon alpha
© Med Uni Graz Impressum